Linxiang Zhao

1.7k total citations
83 papers, 1.3k citations indexed

About

Linxiang Zhao is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Linxiang Zhao has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 37 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Linxiang Zhao's work include Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (11 papers) and Natural product bioactivities and synthesis (9 papers). Linxiang Zhao is often cited by papers focused on Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (11 papers) and Natural product bioactivities and synthesis (9 papers). Linxiang Zhao collaborates with scholars based in China, United States and United Kingdom. Linxiang Zhao's co-authors include Yongkui Jing, Yu Zhou, Kun Xing, Hualiang Jiang, Huan Yu, Jian Zhang, Dan Liu, Tong Tong, Yu Han and Yu Zhang and has published in prestigious journals such as Hepatology, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Linxiang Zhao

75 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linxiang Zhao China 21 722 631 181 109 99 83 1.3k
Atli Thorarensen United States 24 1.2k 1.7× 749 1.2× 156 0.9× 56 0.5× 123 1.2× 45 2.0k
Giovanni Marzaro Italy 21 609 0.8× 578 0.9× 175 1.0× 36 0.3× 85 0.9× 80 1.4k
Niamh M. O’Boyle Ireland 20 825 1.1× 473 0.7× 148 0.8× 58 0.5× 93 0.9× 48 1.3k
Chi-Yen Chang Taiwan 20 759 1.1× 599 0.9× 172 1.0× 47 0.4× 96 1.0× 28 1.3k
Meng Zhou China 21 497 0.7× 583 0.9× 135 0.7× 92 0.8× 96 1.0× 75 1.2k
Xuewei Wu China 15 463 0.6× 693 1.1× 212 1.2× 45 0.4× 127 1.3× 28 1.3k
Randall W. Hungate United States 22 748 1.0× 643 1.0× 141 0.8× 47 0.4× 109 1.1× 51 1.4k
Lalji K. Gediya United States 19 373 0.5× 773 1.2× 168 0.9× 98 0.9× 64 0.6× 26 1.3k
Guisen Zhao China 18 490 0.7× 537 0.9× 123 0.7× 38 0.3× 62 0.6× 58 1.1k
Bahaa Elgendy United States 21 570 0.8× 508 0.8× 201 1.1× 44 0.4× 108 1.1× 62 1.4k

Countries citing papers authored by Linxiang Zhao

Since Specialization
Citations

This map shows the geographic impact of Linxiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxiang Zhao more than expected).

Fields of papers citing papers by Linxiang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linxiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxiang Zhao. The network helps show where Linxiang Zhao may publish in the future.

Co-authorship network of co-authors of Linxiang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Linxiang Zhao. A scholar is included among the top collaborators of Linxiang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linxiang Zhao. Linxiang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yi-Min, Chao Gao, Wenxin Xu, et al.. (2025). The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in HCC. Hepatology. 83(4). 771–788.
2.
Zhao, Linxiang, Hui Liu, Binh Khanh, et al.. (2025). Nonheme Fe 1,3-nitrogen migratases for asymmetric noncanonical amino acid synthesis. Nature Chemical Biology. 21(11). 1773–1782. 3 indexed citations
3.
Zhao, Linxiang, et al.. (2025). Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma. International Journal of Cancer. 158(3). 475–487.
4.
Cai, Tian, Xuebo Yang, Xuena Wang, et al.. (2024). An improved synthetic strategy for the multigram-scale synthesis of DNA–PK inhibitor AZD7648. Chemical Papers. 78(5). 3213–3222. 2 indexed citations
5.
Li, Junhua, Qingqing Hu, Zhiming Chen, et al.. (2024). Optimization of the synthesis of BET BD2 selective inhibitor XY153. Chemistry & Biodiversity. 21(2). e202301584–e202301584. 1 indexed citations
6.
Huang, Min, Ping Gong, Yuetong Wang, et al.. (2020). Synthesis and antitumor effects of novel 18β-glycyrrhetinic acid derivatives featuring an exocyclic α,β-unsaturated carbonyl moiety in ring A. Bioorganic Chemistry. 103. 104187–104187. 12 indexed citations
7.
9.
Huang, Min, Yu Cao, Ping Gong, et al.. (2016). Usnic acid is a novel Pim-1 inhibitor with the abilities of inhibiting growth and inducing apoptosis in human myeloid leukemia cells. RSC Advances. 6(29). 24091–24096. 7 indexed citations
10.
Yao, Hong, et al.. (2016). Enantioselective N‐Heterocyclic Carbene‐Catalyzed [3+3] Annulation of α,β‐Unsaturated Esters with Methyl Ketoimine. Advanced Synthesis & Catalysis. 358(11). 1864–1869. 23 indexed citations
11.
Zhao, Linxiang. (2014). Role of ERO1α and its DNA methylation in homocysteine-induced inhibition of hepatocyte proliferation. Zhongguo yaolixue tongbao. 1 indexed citations
12.
Ji, Xun, Mingbo Su, Jiang Wang, et al.. (2014). Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. European Journal of Medicinal Chemistry. 75. 111–122. 37 indexed citations
13.
Li, Xiaojing, Lei Li, Qingtong Zhou, et al.. (2014). Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(24). 5612–5615. 8 indexed citations
14.
Zhou, Wei, et al.. (2013). The synthesis of novel taxoids for oral administration. Bioorganic & Medicinal Chemistry. 22(1). 194–203. 18 indexed citations
15.
Zhao, Linxiang. (2011). Design and synthesis of novel dihydroartemisinin derivatives containing a substituted chalcone with improved antiproliferative effects in leukemia cells. Shenyang Yaoke Daxue xuebao. 1 indexed citations
16.
Liu, Fang, Xiao Ding, Lei Zhang, et al.. (2010). Silver- and Gold-Mediated Intramolecular Cyclization to Substituted Tetracyclic Isoquinolizinium Hexafluorostilbates. The Journal of Organic Chemistry. 75(17). 5810–5820. 15 indexed citations
17.
Zhao, Linxiang, et al.. (2009). Improved synthesis of milrinone. Zhongguo yaowu huaxue zazhi. 1 indexed citations
18.
Wang, Rui, Chunmin Li, Dandan Song, et al.. (2007). Ethacrynic Acid Butyl-Ester Induces Apoptosis in Leukemia Cells through a Hydrogen Peroxide–Mediated Pathway Independent of GlutathioneS-Transferase P1-1 Inhibition. Cancer Research. 67(16). 7856–7864. 48 indexed citations
19.
Zhao, Linxiang, et al.. (2005). Synthesis of Boswellic Acid Derivatives and Primary Research on their Activities. Chinese Chemical Letters. 16(7). 867–870. 6 indexed citations
20.
Zhao, Linxiang, et al.. (2001). Synthesis and Antitumour Activities of 3-Substituted 4-Oxo-3H-imidazo[5,1-d][1,2,3,5] tetrazine-8-carboxylic Acids and Their Derivatives. Zhongguo yaowu huaxue zazhi. 11(5). 263–269. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026